ifosfamide has been researched along with Dysuria in 2 studies
Dysuria: Painful URINATION. It is often associated with infections of the lower URINARY TRACT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pancreatic Ewing's sarcoma is not reported commonly, with inconsistent clinical manifestations." | 1.72 | Rare presentation in a rare case of pancreatic extraosseous Ewing's sarcoma: A case report. ( Chan, WT; Hou, JY; Jiang, CB; Lee, HC; Liu, HC; Liu, YC; Sheu, JC; Wu, PS; Yeh, TC; Yeung, CY, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, YC | 3 |
| Yeh, TC | 3 |
| Wu, PS | 3 |
| Sheu, JC | 3 |
| Lee, HC | 3 |
| Yeung, CY | 3 |
| Jiang, CB | 3 |
| Liu, HC | 3 |
| Hou, JY | 3 |
| Chan, WT | 3 |
| Yamamoto, Y | 1 |
| Tsukiyama, I | 1 |
| Nii, S | 1 |
| Harada, R | 1 |
| Watanabe, K | 1 |
| Yabushita, H | 1 |
| Wakatsuki, A | 1 |
| Saito, H | 1 |
| Hasegawa, T | 1 |
2 other studies available for ifosfamide and Dysuria
| Article | Year |
|---|---|
Rare presentation in a rare case of pancreatic extraosseous Ewing's sarcoma: A case report.
Topics: Adolescent; Cyclophosphamide; Dysuria; Epirubicin; Etoposide; Flank Pain; Humans; Ifosfamide; Male; | 2022 |
Rare presentation in a rare case of pancreatic extraosseous Ewing's sarcoma: A case report.
Topics: Adolescent; Cyclophosphamide; Dysuria; Epirubicin; Etoposide; Flank Pain; Humans; Ifosfamide; Male; | 2022 |
Rare presentation in a rare case of pancreatic extraosseous Ewing's sarcoma: A case report.
Topics: Adolescent; Cyclophosphamide; Dysuria; Epirubicin; Etoposide; Flank Pain; Humans; Ifosfamide; Male; | 2022 |
Rare presentation in a rare case of pancreatic extraosseous Ewing's sarcoma: A case report.
Topics: Adolescent; Cyclophosphamide; Dysuria; Epirubicin; Etoposide; Flank Pain; Humans; Ifosfamide; Male; | 2022 |
[A case of Ifosfamide-induced dysuria which could be avoided by changing the regimen of mesna].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dysuria; Female; Humans; Ifosfamid | 2013 |